Mandatory R&D Limit In Pharma FDI Policy
  • Elizabeth George
  • Oct 09 2013

October 9: The government is all set to overhaul the pharma FDI policy and it’s said to be working on mandating the minimum required expenditure of 20% year-on-year on R&D in India. The government is concerned about the limited R&D in India but the proposal has met with strong opposition and there has been no consensus as yet on the exact limit.